Table 2. Cardiovascular medication use in patients with chronic heart failure.
Agents | n (%) |
ACE inhibitors or ARBs | 394 (58.2) |
ACE inhibitors | 296 (43.7) |
ARBs | 121 (17.9) |
ACE inhibitors + ARBs | 23 (3.3) |
β-blockers | 235 (34.7) |
ACE inhibitors +β-blockers | 130 ( 19.2) |
Diuretics | 488 (72.0) |
Digoxin | 126 (18.6) |
Spironolactone | 78 (11.5) |
CCBs | 74 (10.9) |
DHPs | 46 (6.8) |
Non-DHPs | 28 (4.1) |
Statins | 148 (21.9) |
Aspirin | 257 (38.0) |
Clopidogrel | 35 (5.2) |
Warfarin | 141 (20.8) |
Amidarone | 34 (5.0) |
Sotalol | 10 (1.5) |
Nirates | 94 (13.9) |
ACE: angiotensin converting enzyme; ARBs: angiotensin receptor blockers; CCB: calcium channel blocker; DHPs: dihydropyridines.